What is the most common adverse event associated with the use of tumor treating fields therapy?
Two thirds of the patients randomized to the TTFields continued treatment with the device after first progression. The most common adverse event related to the device was skin irritation, occurring in 43% of patients (2% grade 3 or higher).
What is the importance of tumor treating field?
A device, termed tumor-treating fields, delivers low intensity, intermediate-frequency alternating electric fields. Alternating electric fields disrupt mitosis leading to apoptosis of rapidly dividing cells in both cellular and animal models.
What are treatment fields?
Listen to pronunciation. (TREET-ment feeld) In radiation therapy, the place on the body where the radiation beam is aimed.
Can a tumor be treated with medication?
Cancer treatment is the use of surgery, radiation, medications and other therapies to cure a cancer, shrink a cancer or stop the progression of a cancer. Many cancer treatments exist. Depending on your particular situation, you may receive one treatment or you may receive a combination of treatments.
How many months do you use optune?
average patient usage of Optune for the first 6 months of treatment (months 1-6).
How many months do you wear optune?
How long do I have to wear Optune? A large clinical study showed that Optune should be worn for at least 75% of the time (18 hours per day) to get the best response from treatment. When you begin treatment with Optune, work with your doctor to decide how long you should stay on Optune based on your needs.
What is the role of tumor treating fields in newly diagnosed glioblastoma?
The device that utilizes this mechanism is known as tumor-treating fields (TTFields). TTFields can be applied by ceramic transducer arrays on a shaved scalp to deliver the alternating electric activity to patients with glioblastoma (GBM). It has FDA approval for use in both recurrent and newly diagnosed GBM.
What is Avastin made from?
Bevacizumab, the active ingredient of Avastin, is a recombinant humanised monoclonal immunoglobulin G1 (IgG1) antibody (93% human, 7% murine sequences – molecular weight 149 kDa) that selectively binds with high affinity to all isoforms of human vascular endothelial growth factor (VEGF) and neutralises VEGF’s biologic …
How does electric field therapy work?
The TTFields electric charge prevents the cancer cell from dividing, thereby preventing the cancer from growing and spreading. TFF prevents division and destroys cancers cells with electric fields while sparing healthy tissue.